Cousins, Bruce Gordon — Insider Profile

Insider Profile

Cousins, Bruce Gordon

$EPRX

Companies Filed At

Open-Market Buys (2yr)

—

Buy Value (2yr, open-market)

May 28, 2024

Most Recent Trade

Credibility
Score

Hit Rate

-7.3%

Avg 90d Return

-7.3%

Median 90d Return

Evaluated Trades

-6.3%

Best Trade

-8.4%

Worst Trade

Hit rate and returns are based on 2 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
May 28, 2024	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	50,000	$3.82	$191K	60
May 13, 2024	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	35,000	$3.96	$139K	60
Aug 18, 2023	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Sell	14,286	$7.00	$100K	60

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Signal scores reflect the company's current score, not the score at time of trade.